nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Hydrocortisone—atopic dermatitis	0.218	0.537	CrCtD
Danazol—Prednisone—atopic dermatitis	0.188	0.463	CrCtD
Danazol—PGR—Betamethasone—atopic dermatitis	0.0426	0.225	CbGbCtD
Danazol—SHBG—Hydrocortisone—atopic dermatitis	0.0382	0.202	CbGbCtD
Danazol—PGR—Dexamethasone—atopic dermatitis	0.0248	0.131	CbGbCtD
Danazol—CYP19A1—Betamethasone—atopic dermatitis	0.0239	0.127	CbGbCtD
Danazol—Testolactone—Desonide—atopic dermatitis	0.0168	0.0566	CrCrCtD
Danazol—Prednisone—Desonide—atopic dermatitis	0.015	0.0507	CrCrCtD
Danazol—CYP19A1—Dexamethasone—atopic dermatitis	0.0139	0.0737	CbGbCtD
Danazol—Hydrocortisone—Desonide—atopic dermatitis	0.0122	0.0414	CrCrCtD
Danazol—CYP3A4—Pimecrolimus—atopic dermatitis	0.0117	0.062	CbGbCtD
Danazol—Formestane—Hydrocortisone—atopic dermatitis	0.0106	0.0356	CrCrCtD
Danazol—Testolactone—Mometasone—atopic dermatitis	0.0104	0.0352	CrCrCtD
Danazol—Fluoxymesterone—Mometasone—atopic dermatitis	0.00958	0.0323	CrCrCtD
Danazol—Prednisone—Mometasone—atopic dermatitis	0.00933	0.0315	CrCrCtD
Danazol—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.00873	0.0295	CrCrCtD
Danazol—Hydrocortisone—Mometasone—atopic dermatitis	0.00761	0.0257	CrCrCtD
Danazol—Norethindrone—Hydrocortisone—atopic dermatitis	0.00701	0.0237	CrCrCtD
Danazol—CYP3A4—Tacrolimus—atopic dermatitis	0.00697	0.0369	CbGbCtD
Danazol—Cortisone acetate—Hydrocortisone—atopic dermatitis	0.0068	0.0229	CrCrCtD
Danazol—Cortisone acetate—Methylprednisolone—atopic dermatitis	0.00641	0.0217	CrCrCtD
Danazol—Testolactone—Methylprednisolone—atopic dermatitis	0.00622	0.021	CrCrCtD
Danazol—Testolactone—Dexamethasone—atopic dermatitis	0.00612	0.0207	CrCrCtD
Danazol—Testolactone—Betamethasone—atopic dermatitis	0.00612	0.0207	CrCrCtD
Danazol—Fluoxymesterone—Hydrocortisone—atopic dermatitis	0.00606	0.0205	CrCrCtD
Danazol—Testolactone—Triamcinolone—atopic dermatitis	0.00598	0.0202	CrCrCtD
Danazol—Prednisone—Hydrocortisone—atopic dermatitis	0.0059	0.0199	CrCrCtD
Danazol—Progesterone—Hydrocortisone—atopic dermatitis	0.0059	0.0199	CrCrCtD
Danazol—Testosterone Propionate—Hydrocortisone—atopic dermatitis	0.0059	0.0199	CrCrCtD
Danazol—Cortisone acetate—Prednisone—atopic dermatitis	0.00585	0.0198	CrCrCtD
Danazol—Methyltestosterone—Hydrocortisone—atopic dermatitis	0.00576	0.0194	CrCrCtD
Danazol—Cortisone acetate—Prednisolone—atopic dermatitis	0.00571	0.0193	CrCrCtD
Danazol—Testolactone—Prednisone—atopic dermatitis	0.00568	0.0192	CrCrCtD
Danazol—Fluoxymesterone—Dexamethasone—atopic dermatitis	0.00563	0.019	CrCrCtD
Danazol—Fluoxymesterone—Betamethasone—atopic dermatitis	0.00563	0.019	CrCrCtD
Danazol—Prednisone—Methylprednisolone—atopic dermatitis	0.00557	0.0188	CrCrCtD
Danazol—Testolactone—Prednisolone—atopic dermatitis	0.00554	0.0187	CrCrCtD
Danazol—Fluoxymesterone—Triamcinolone—atopic dermatitis	0.0055	0.0186	CrCrCtD
Danazol—Prednisone—Betamethasone—atopic dermatitis	0.00548	0.0185	CrCrCtD
Danazol—Prednisone—Dexamethasone—atopic dermatitis	0.00548	0.0185	CrCrCtD
Danazol—Prednisone—Triamcinolone—atopic dermatitis	0.00536	0.0181	CrCrCtD
Danazol—Testosterone—Hydrocortisone—atopic dermatitis	0.00512	0.0173	CrCrCtD
Danazol—CYP3A4—Loratadine—atopic dermatitis	0.0051	0.027	CbGbCtD
Danazol—Fluoxymesterone—Prednisolone—atopic dermatitis	0.00509	0.0172	CrCrCtD
Danazol—Progesterone—Prednisolone—atopic dermatitis	0.00496	0.0168	CrCrCtD
Danazol—Prednisone—Prednisolone—atopic dermatitis	0.00496	0.0168	CrCrCtD
Danazol—Methyltestosterone—Prednisone—atopic dermatitis	0.00496	0.0167	CrCrCtD
Danazol—Methyltestosterone—Prednisolone—atopic dermatitis	0.00484	0.0163	CrCrCtD
Danazol—CYP3A4—Methylprednisolone—atopic dermatitis	0.00467	0.0247	CbGbCtD
Danazol—Hydrocortisone—Methylprednisolone—atopic dermatitis	0.00454	0.0153	CrCrCtD
Danazol—Hydrocortisone—Dexamethasone—atopic dermatitis	0.00447	0.0151	CrCrCtD
Danazol—Hydrocortisone—Betamethasone—atopic dermatitis	0.00447	0.0151	CrCrCtD
Danazol—Hydrocortisone—Triamcinolone—atopic dermatitis	0.00437	0.0148	CrCrCtD
Danazol—Testosterone—Prednisolone—atopic dermatitis	0.00431	0.0145	CrCrCtD
Danazol—Hydrocortisone—Prednisone—atopic dermatitis	0.00415	0.014	CrCrCtD
Danazol—Hydrocortisone—Prednisolone—atopic dermatitis	0.00405	0.0137	CrCrCtD
Danazol—CYP3A4—Triamcinolone—atopic dermatitis	0.00354	0.0187	CbGbCtD
Danazol—CYP3A4—Betamethasone—atopic dermatitis	0.00303	0.0161	CbGbCtD
Danazol—CYP3A4—Prednisolone—atopic dermatitis	0.00299	0.0158	CbGbCtD
Danazol—CYP3A4—Hydrocortisone—atopic dermatitis	0.00284	0.015	CbGbCtD
Danazol—CYP3A4—Prednisone—atopic dermatitis	0.00283	0.015	CbGbCtD
Danazol—CCL2—skin epidermis—atopic dermatitis	0.00214	0.31	CbGeAlD
Danazol—CYP3A4—Dexamethasone—atopic dermatitis	0.00176	0.00934	CbGbCtD
Danazol—CCL2—neck—atopic dermatitis	0.00102	0.148	CbGeAlD
Danazol—CCL2—skin of body—atopic dermatitis	0.000663	0.0961	CbGeAlD
Danazol—SHBG—neck—atopic dermatitis	0.000597	0.0866	CbGeAlD
Danazol—GNRHR—head—atopic dermatitis	0.000554	0.0803	CbGeAlD
Danazol—CCL2—head—atopic dermatitis	0.000432	0.0627	CbGeAlD
Danazol—ESR1—neck—atopic dermatitis	0.000421	0.061	CbGeAlD
Danazol—AR—skin of body—atopic dermatitis	0.000278	0.0402	CbGeAlD
Danazol—PGR—head—atopic dermatitis	0.000227	0.033	CbGeAlD
Danazol—CYP19A1—head—atopic dermatitis	0.000205	0.0297	CbGeAlD
Danazol—AR—head—atopic dermatitis	0.000181	0.0263	CbGeAlD
Danazol—ESR1—head—atopic dermatitis	0.000178	0.0258	CbGeAlD
Danazol—ESR1—Nuclear Receptors—PPARA—atopic dermatitis	0.000113	0.00273	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CCL11—atopic dermatitis	0.00011	0.00265	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL5—atopic dermatitis	0.000109	0.00264	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—IL6—atopic dermatitis	0.000109	0.00263	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000107	0.00259	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000106	0.00257	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000105	0.00253	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000105	0.00253	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000103	0.00249	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000103	0.00248	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—GLB1—atopic dermatitis	0.000102	0.00246	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCL11—atopic dermatitis	0.0001	0.00242	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL5—atopic dermatitis	9.71e-05	0.00235	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	9.59e-05	0.00232	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	9.57e-05	0.00231	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	9.57e-05	0.00231	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TNF—atopic dermatitis	9.4e-05	0.00227	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	9.38e-05	0.00227	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IL6—atopic dermatitis	9.32e-05	0.00225	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—atopic dermatitis	9.21e-05	0.00223	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IFNG—atopic dermatitis	9.13e-05	0.00221	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	9.11e-05	0.0022	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CCR3—atopic dermatitis	8.94e-05	0.00216	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	8.91e-05	0.00215	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CCL22—atopic dermatitis	8.73e-05	0.00211	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL13—atopic dermatitis	8.72e-05	0.00211	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—CXCL8—atopic dermatitis	8.49e-05	0.00205	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	8.29e-05	0.002	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCR3—atopic dermatitis	8.17e-05	0.00198	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL1B—atopic dermatitis	8.14e-05	0.00197	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL2—atopic dermatitis	8.11e-05	0.00196	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—CD4—atopic dermatitis	8.09e-05	0.00195	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	8.02e-05	0.00194	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CASP8—atopic dermatitis	8e-05	0.00193	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL22—atopic dermatitis	7.99e-05	0.00193	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL10—atopic dermatitis	7.98e-05	0.00193	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—TAC1—atopic dermatitis	7.97e-05	0.00193	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—NPS—atopic dermatitis	7.97e-05	0.00193	CbGpPWpGaD
Danazol—Acute coronary syndrome—Prednisolone—atopic dermatitis	7.95e-05	0.00137	CcSEcCtD
Danazol—Shock—Tacrolimus—atopic dermatitis	7.92e-05	0.00137	CcSEcCtD
Danazol—Myocardial infarction—Prednisolone—atopic dermatitis	7.9e-05	0.00136	CcSEcCtD
Danazol—Thrombocytopenia—Tacrolimus—atopic dermatitis	7.88e-05	0.00136	CcSEcCtD
Danazol—Tachycardia—Tacrolimus—atopic dermatitis	7.86e-05	0.00136	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—CCL27—atopic dermatitis	7.84e-05	0.00189	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CXCR3—atopic dermatitis	7.81e-05	0.00189	CbGpPWpGaD
Danazol—Dizziness—Loratadine—atopic dermatitis	7.79e-05	0.00135	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CCL27—atopic dermatitis	7.78e-05	0.00188	CbGpPWpGaD
Danazol—Hyperhidrosis—Tacrolimus—atopic dermatitis	7.78e-05	0.00134	CcSEcCtD
Danazol—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	7.76e-05	0.00134	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—IL4—atopic dermatitis	7.76e-05	0.00188	CbGpPWpGaD
Danazol—Myocardial infarction—Hydrocortisone—atopic dermatitis	7.72e-05	0.00133	CcSEcCtD
Danazol—CCL2—Metabolism of proteins—CMA1—atopic dermatitis	7.71e-05	0.00186	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL6—atopic dermatitis	7.59e-05	0.00183	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	7.58e-05	0.00183	CbGpPWpGaD
Danazol—Weight increased—Triamcinolone—atopic dermatitis	7.57e-05	0.00131	CcSEcCtD
Danazol—Weight increased—Methylprednisolone—atopic dermatitis	7.55e-05	0.0013	CcSEcCtD
Danazol—Pruritus—Fluocinolone Acetonide—atopic dermatitis	7.49e-05	0.00129	CcSEcCtD
Danazol—Vomiting—Loratadine—atopic dermatitis	7.49e-05	0.00129	CcSEcCtD
Danazol—Affect lability—Prednisone—atopic dermatitis	7.48e-05	0.00129	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—TNF—atopic dermatitis	7.47e-05	0.00181	CbGpPWpGaD
Danazol—Rash—Loratadine—atopic dermatitis	7.43e-05	0.00128	CcSEcCtD
Danazol—Dermatitis—Loratadine—atopic dermatitis	7.42e-05	0.00128	CcSEcCtD
Danazol—Headache—Loratadine—atopic dermatitis	7.38e-05	0.00127	CcSEcCtD
Danazol—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	7.33e-05	0.00127	CcSEcCtD
Danazol—Acute coronary syndrome—Triamcinolone—atopic dermatitis	7.31e-05	0.00126	CcSEcCtD
Danazol—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	7.29e-05	0.00126	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—TAC1—atopic dermatitis	7.29e-05	0.00176	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—NPS—atopic dermatitis	7.29e-05	0.00176	CbGpPWpGaD
Danazol—Haemoglobin—Prednisolone—atopic dermatitis	7.27e-05	0.00126	CcSEcCtD
Danazol—Myocardial infarction—Triamcinolone—atopic dermatitis	7.27e-05	0.00125	CcSEcCtD
Danazol—Asthenia—Mometasone—atopic dermatitis	7.26e-05	0.00125	CcSEcCtD
Danazol—Irritability—Prednisone—atopic dermatitis	7.26e-05	0.00125	CcSEcCtD
Danazol—Myocardial infarction—Methylprednisolone—atopic dermatitis	7.25e-05	0.00125	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—IL6—atopic dermatitis	7.24e-05	0.00175	CbGpPWpGaD
Danazol—Haemorrhage—Prednisolone—atopic dermatitis	7.24e-05	0.00125	CcSEcCtD
Danazol—Paraesthesia—Tacrolimus—atopic dermatitis	7.23e-05	0.00125	CcSEcCtD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—atopic dermatitis	7.21e-05	0.00174	CbGpPWpGaD
Danazol—Mood swings—Prednisone—atopic dermatitis	7.2e-05	0.00124	CcSEcCtD
Danazol—Pruritus—Mometasone—atopic dermatitis	7.16e-05	0.00124	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—CXCR3—atopic dermatitis	7.15e-05	0.00173	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.14e-05	0.00173	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL27—atopic dermatitis	7.12e-05	0.00172	CbGpPWpGaD
Danazol—Haemoglobin—Hydrocortisone—atopic dermatitis	7.1e-05	0.00123	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—atopic dermatitis	7.1e-05	0.00172	CbGpPWpGaD
Danazol—Sweating—Methylprednisolone—atopic dermatitis	7.09e-05	0.00122	CcSEcCtD
Danazol—Dyspepsia—Tacrolimus—atopic dermatitis	7.09e-05	0.00122	CcSEcCtD
Danazol—Haemorrhage—Hydrocortisone—atopic dermatitis	7.07e-05	0.00122	CcSEcCtD
Danazol—Dizziness—Fluocinolone Acetonide—atopic dermatitis	7e-05	0.00121	CcSEcCtD
Danazol—Nausea—Loratadine—atopic dermatitis	7e-05	0.00121	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CCL17—atopic dermatitis	6.98e-05	0.00169	CbGpPWpGaD
Danazol—Visual impairment—Prednisolone—atopic dermatitis	6.97e-05	0.0012	CcSEcCtD
Danazol—Fatigue—Tacrolimus—atopic dermatitis	6.94e-05	0.0012	CcSEcCtD
Danazol—Constipation—Tacrolimus—atopic dermatitis	6.88e-05	0.00119	CcSEcCtD
Danazol—Weight increased—Betamethasone—atopic dermatitis	6.87e-05	0.00119	CcSEcCtD
Danazol—Weight increased—Dexamethasone—atopic dermatitis	6.87e-05	0.00119	CcSEcCtD
Danazol—Vomiting—Fluocinolone Acetonide—atopic dermatitis	6.74e-05	0.00116	CcSEcCtD
Danazol—Haemoglobin—Triamcinolone—atopic dermatitis	6.69e-05	0.00115	CcSEcCtD
Danazol—Rash—Fluocinolone Acetonide—atopic dermatitis	6.68e-05	0.00115	CcSEcCtD
Danazol—Haemoglobin—Methylprednisolone—atopic dermatitis	6.67e-05	0.00115	CcSEcCtD
Danazol—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	6.67e-05	0.00115	CcSEcCtD
Danazol—Haemorrhage—Triamcinolone—atopic dermatitis	6.66e-05	0.00115	CcSEcCtD
Danazol—Haemorrhage—Methylprednisolone—atopic dermatitis	6.64e-05	0.00115	CcSEcCtD
Danazol—Headache—Fluocinolone Acetonide—atopic dermatitis	6.64e-05	0.00115	CcSEcCtD
Danazol—Acute coronary syndrome—Betamethasone—atopic dermatitis	6.63e-05	0.00114	CcSEcCtD
Danazol—Acute coronary syndrome—Dexamethasone—atopic dermatitis	6.63e-05	0.00114	CcSEcCtD
Danazol—Myocardial infarction—Dexamethasone—atopic dermatitis	6.59e-05	0.00114	CcSEcCtD
Danazol—Myocardial infarction—Betamethasone—atopic dermatitis	6.59e-05	0.00114	CcSEcCtD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.53e-05	0.00158	CbGpPWpGaD
Danazol—Pancreatitis—Prednisone—atopic dermatitis	6.44e-05	0.00111	CcSEcCtD
Danazol—Vomiting—Mometasone—atopic dermatitis	6.43e-05	0.00111	CcSEcCtD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.43e-05	0.00155	CbGpPWpGaD
Danazol—Visual impairment—Methylprednisolone—atopic dermatitis	6.4e-05	0.0011	CcSEcCtD
Danazol—Urticaria—Tacrolimus—atopic dermatitis	6.4e-05	0.0011	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—CCL17—atopic dermatitis	6.38e-05	0.00154	CbGpPWpGaD
Danazol—Rash—Mometasone—atopic dermatitis	6.38e-05	0.0011	CcSEcCtD
Danazol—Dermatitis—Mometasone—atopic dermatitis	6.37e-05	0.0011	CcSEcCtD
Danazol—Body temperature increased—Tacrolimus—atopic dermatitis	6.36e-05	0.0011	CcSEcCtD
Danazol—Headache—Mometasone—atopic dermatitis	6.34e-05	0.00109	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—CXCL10—atopic dermatitis	6.31e-05	0.00153	CbGpPWpGaD
Danazol—CCL2—Methylprednisolone—Desonide—atopic dermatitis	6.31e-05	0.023	CbGdCrCtD
Danazol—Nausea—Fluocinolone Acetonide—atopic dermatitis	6.29e-05	0.00109	CcSEcCtD
Danazol—AR—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	6.22e-05	0.0015	CbGpPWpGaD
Danazol—Haemoglobin—Betamethasone—atopic dermatitis	6.07e-05	0.00105	CcSEcCtD
Danazol—Haemoglobin—Dexamethasone—atopic dermatitis	6.07e-05	0.00105	CcSEcCtD
Danazol—Haemorrhage—Dexamethasone—atopic dermatitis	6.04e-05	0.00104	CcSEcCtD
Danazol—Haemorrhage—Betamethasone—atopic dermatitis	6.04e-05	0.00104	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—IL6—atopic dermatitis	6.03e-05	0.00146	CbGpPWpGaD
Danazol—Nausea—Mometasone—atopic dermatitis	6.01e-05	0.00104	CcSEcCtD
Danazol—Weight increased—Prednisone—atopic dermatitis	5.98e-05	0.00103	CcSEcCtD
Danazol—Vision blurred—Prednisolone—atopic dermatitis	5.94e-05	0.00102	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—TNF—atopic dermatitis	5.91e-05	0.00143	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.88e-05	0.00142	CbGpPWpGaD
Danazol—Visual impairment—Dexamethasone—atopic dermatitis	5.82e-05	0.001	CcSEcCtD
Danazol—Visual impairment—Betamethasone—atopic dermatitis	5.82e-05	0.001	CcSEcCtD
Danazol—CCL2—TNF alpha Signaling Pathway—IL6—atopic dermatitis	5.82e-05	0.00141	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	5.8e-05	0.0014	CbGpPWpGaD
Danazol—Asthenia—Tacrolimus—atopic dermatitis	5.78e-05	0.000997	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—CXCL10—atopic dermatitis	5.78e-05	0.0014	CbGpPWpGaD
Danazol—Acute coronary syndrome—Prednisone—atopic dermatitis	5.78e-05	0.000997	CcSEcCtD
Danazol—Myocardial infarction—Prednisone—atopic dermatitis	5.74e-05	0.000991	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	5.71e-05	0.00138	CbGpPWpGaD
Danazol—Pruritus—Tacrolimus—atopic dermatitis	5.7e-05	0.000983	CcSEcCtD
Danazol—Vertigo—Prednisolone—atopic dermatitis	5.66e-05	0.000977	CcSEcCtD
Danazol—CCL2—Beclomethasone—Desonide—atopic dermatitis	5.65e-05	0.0206	CbGdCrCtD
Danazol—Syncope—Prednisolone—atopic dermatitis	5.65e-05	0.000975	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CCL11—atopic dermatitis	5.63e-05	0.00136	CbGpPWpGaD
Danazol—Back pain—Triamcinolone—atopic dermatitis	5.6e-05	0.000967	CcSEcCtD
Danazol—CCL2—Signaling Pathways—FCER2—atopic dermatitis	5.55e-05	0.00134	CbGpPWpGaD
Danazol—Loss of consciousness—Prednisolone—atopic dermatitis	5.54e-05	0.000956	CcSEcCtD
Danazol—Vertigo—Hydrocortisone—atopic dermatitis	5.53e-05	0.000954	CcSEcCtD
Danazol—Syncope—Hydrocortisone—atopic dermatitis	5.52e-05	0.000952	CcSEcCtD
Danazol—Convulsion—Prednisolone—atopic dermatitis	5.46e-05	0.000942	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL10—atopic dermatitis	5.45e-05	0.00132	CbGpPWpGaD
Danazol—Hypertension—Prednisolone—atopic dermatitis	5.44e-05	0.000939	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—CCL5—atopic dermatitis	5.44e-05	0.00131	CbGpPWpGaD
Danazol—Loss of consciousness—Hydrocortisone—atopic dermatitis	5.41e-05	0.000933	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—IFNG—atopic dermatitis	5.38e-05	0.0013	CbGpPWpGaD
Danazol—Alopecia—Betamethasone—atopic dermatitis	5.34e-05	0.000921	CcSEcCtD
Danazol—Alopecia—Dexamethasone—atopic dermatitis	5.34e-05	0.000921	CcSEcCtD
Danazol—Convulsion—Hydrocortisone—atopic dermatitis	5.33e-05	0.00092	CcSEcCtD
Danazol—Dizziness—Tacrolimus—atopic dermatitis	5.32e-05	0.000919	CcSEcCtD
Danazol—Hypertension—Hydrocortisone—atopic dermatitis	5.31e-05	0.000917	CcSEcCtD
Danazol—Haemoglobin—Prednisone—atopic dermatitis	5.29e-05	0.000912	CcSEcCtD
Danazol—Haemorrhage—Prednisone—atopic dermatitis	5.26e-05	0.000908	CcSEcCtD
Danazol—Anxiety—Hydrocortisone—atopic dermatitis	5.22e-05	0.000901	CcSEcCtD
Danazol—CCL2—Fluocinonide—Desonide—atopic dermatitis	5.22e-05	0.019	CbGdCrCtD
Danazol—Vertigo—Triamcinolone—atopic dermatitis	5.21e-05	0.000898	CcSEcCtD
Danazol—Syncope—Triamcinolone—atopic dermatitis	5.2e-05	0.000897	CcSEcCtD
Danazol—Vertigo—Methylprednisolone—atopic dermatitis	5.19e-05	0.000896	CcSEcCtD
Danazol—Syncope—Methylprednisolone—atopic dermatitis	5.18e-05	0.000895	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CCL22—atopic dermatitis	5.16e-05	0.00125	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL11—atopic dermatitis	5.15e-05	0.00124	CbGpPWpGaD
Danazol—Oedema—Prednisolone—atopic dermatitis	5.14e-05	0.000887	CcSEcCtD
Danazol—Vomiting—Tacrolimus—atopic dermatitis	5.12e-05	0.000883	CcSEcCtD
Danazol—Loss of consciousness—Triamcinolone—atopic dermatitis	5.09e-05	0.000879	CcSEcCtD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	5.09e-05	0.00123	CbGpPWpGaD
Danazol—Loss of consciousness—Methylprednisolone—atopic dermatitis	5.08e-05	0.000877	CcSEcCtD
Danazol—Rash—Tacrolimus—atopic dermatitis	5.08e-05	0.000876	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—FCER2—atopic dermatitis	5.07e-05	0.00123	CbGpPWpGaD
Danazol—Dermatitis—Tacrolimus—atopic dermatitis	5.07e-05	0.000875	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—NGF—atopic dermatitis	5.07e-05	0.00123	CbGpPWpGaD
Danazol—Shock—Prednisolone—atopic dermatitis	5.06e-05	0.000873	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Fluocinonide—atopic dermatitis	5.05e-05	0.0184	CbGdCrCtD
Danazol—Headache—Tacrolimus—atopic dermatitis	5.04e-05	0.00087	CcSEcCtD
Danazol—Oedema—Hydrocortisone—atopic dermatitis	5.02e-05	0.000867	CcSEcCtD
Danazol—Convulsion—Triamcinolone—atopic dermatitis	5.02e-05	0.000866	CcSEcCtD
Danazol—Tachycardia—Prednisolone—atopic dermatitis	5.02e-05	0.000866	CcSEcCtD
Danazol—Convulsion—Methylprednisolone—atopic dermatitis	5.01e-05	0.000864	CcSEcCtD
Danazol—Hypertension—Triamcinolone—atopic dermatitis	5e-05	0.000863	CcSEcCtD
Danazol—CCL2—Amcinonide—Desonide—atopic dermatitis	5e-05	0.0182	CbGdCrCtD
Danazol—ESR1—ATF-2 transcription factor network—CXCL8—atopic dermatitis	5e-05	0.00121	CbGpPWpGaD
Danazol—Hypertension—Methylprednisolone—atopic dermatitis	4.99e-05	0.000861	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—CCL5—atopic dermatitis	4.97e-05	0.0012	CbGpPWpGaD
Danazol—Hyperhidrosis—Prednisolone—atopic dermatitis	4.97e-05	0.000858	CcSEcCtD
Danazol—Shock—Hydrocortisone—atopic dermatitis	4.94e-05	0.000853	CcSEcCtD
Danazol—Arthralgia—Methylprednisolone—atopic dermatitis	4.92e-05	0.000849	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Fluocinolone Acetonide—atopic dermatitis	4.91e-05	0.0179	CbGdCrCtD
Danazol—Anxiety—Methylprednisolone—atopic dermatitis	4.9e-05	0.000846	CcSEcCtD
Danazol—Tachycardia—Hydrocortisone—atopic dermatitis	4.9e-05	0.000846	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—CCR5—atopic dermatitis	4.9e-05	0.00118	CbGpPWpGaD
Danazol—Flushing—Prednisone—atopic dermatitis	4.88e-05	0.000842	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.86e-05	0.00117	CbGpPWpGaD
Danazol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.85e-05	0.000838	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—IFNG—atopic dermatitis	4.8e-05	0.00116	CbGpPWpGaD
Danazol—Nausea—Tacrolimus—atopic dermatitis	4.78e-05	0.000825	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—IL6—atopic dermatitis	4.77e-05	0.00115	CbGpPWpGaD
Danazol—Oedema—Triamcinolone—atopic dermatitis	4.73e-05	0.000816	CcSEcCtD
Danazol—Vertigo—Dexamethasone—atopic dermatitis	4.72e-05	0.000815	CcSEcCtD
Danazol—Vertigo—Betamethasone—atopic dermatitis	4.72e-05	0.000815	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—CCL22—atopic dermatitis	4.72e-05	0.00114	CbGpPWpGaD
Danazol—Syncope—Dexamethasone—atopic dermatitis	4.71e-05	0.000814	CcSEcCtD
Danazol—Syncope—Betamethasone—atopic dermatitis	4.71e-05	0.000814	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—IFNG—atopic dermatitis	4.69e-05	0.00113	CbGpPWpGaD
Danazol—Shock—Triamcinolone—atopic dermatitis	4.65e-05	0.000803	CcSEcCtD
Danazol—Alopecia—Prednisone—atopic dermatitis	4.65e-05	0.000802	CcSEcCtD
Danazol—Shock—Methylprednisolone—atopic dermatitis	4.64e-05	0.000801	CcSEcCtD
Danazol—Loss of consciousness—Dexamethasone—atopic dermatitis	4.62e-05	0.000797	CcSEcCtD
Danazol—Loss of consciousness—Betamethasone—atopic dermatitis	4.62e-05	0.000797	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—CCR3—atopic dermatitis	4.62e-05	0.00112	CbGpPWpGaD
Danazol—Paraesthesia—Prednisolone—atopic dermatitis	4.62e-05	0.000797	CcSEcCtD
Danazol—Tachycardia—Triamcinolone—atopic dermatitis	4.62e-05	0.000797	CcSEcCtD
Danazol—Tachycardia—Methylprednisolone—atopic dermatitis	4.6e-05	0.000795	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CCL27—atopic dermatitis	4.6e-05	0.00111	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CCR3—atopic dermatitis	4.59e-05	0.00111	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.58e-05	0.00079	CcSEcCtD
Danazol—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.57e-05	0.000789	CcSEcCtD
Danazol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.56e-05	0.000787	CcSEcCtD
Danazol—Convulsion—Dexamethasone—atopic dermatitis	4.56e-05	0.000786	CcSEcCtD
Danazol—Convulsion—Betamethasone—atopic dermatitis	4.56e-05	0.000786	CcSEcCtD
Danazol—Hypertension—Dexamethasone—atopic dermatitis	4.54e-05	0.000783	CcSEcCtD
Danazol—Hypertension—Betamethasone—atopic dermatitis	4.54e-05	0.000783	CcSEcCtD
Danazol—CCL2—Beclomethasone—Fluocinonide—atopic dermatitis	4.53e-05	0.0165	CbGdCrCtD
Danazol—Paraesthesia—Hydrocortisone—atopic dermatitis	4.51e-05	0.000778	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—CCR5—atopic dermatitis	4.48e-05	0.00108	CbGpPWpGaD
Danazol—Anxiety—Betamethasone—atopic dermatitis	4.46e-05	0.00077	CcSEcCtD
Danazol—Anxiety—Dexamethasone—atopic dermatitis	4.46e-05	0.00077	CcSEcCtD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.45e-05	0.00108	CbGpPWpGaD
Danazol—Dyspepsia—Hydrocortisone—atopic dermatitis	4.42e-05	0.000763	CcSEcCtD
Danazol—CCL2—Beclomethasone—Fluocinolone Acetonide—atopic dermatitis	4.4e-05	0.016	CbGdCrCtD
Danazol—ESR1—ATF-2 transcription factor network—MAPK8—atopic dermatitis	4.4e-05	0.00106	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CXCL8—atopic dermatitis	4.36e-05	0.00105	CbGpPWpGaD
Danazol—Fatigue—Hydrocortisone—atopic dermatitis	4.33e-05	0.000747	CcSEcCtD
Danazol—Vision blurred—Prednisone—atopic dermatitis	4.31e-05	0.000745	CcSEcCtD
Danazol—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	4.31e-05	0.000744	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	4.3e-05	0.000742	CcSEcCtD
Danazol—Oedema—Dexamethasone—atopic dermatitis	4.29e-05	0.000741	CcSEcCtD
Danazol—Oedema—Betamethasone—atopic dermatitis	4.29e-05	0.000741	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—IL2—atopic dermatitis	4.27e-05	0.00103	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.25e-05	0.00103	CbGpPWpGaD
Danazol—Paraesthesia—Triamcinolone—atopic dermatitis	4.25e-05	0.000733	CcSEcCtD
Danazol—Paraesthesia—Methylprednisolone—atopic dermatitis	4.24e-05	0.000731	CcSEcCtD
Danazol—Shock—Betamethasone—atopic dermatitis	4.22e-05	0.000729	CcSEcCtD
Danazol—Shock—Dexamethasone—atopic dermatitis	4.22e-05	0.000729	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—CCL27—atopic dermatitis	4.2e-05	0.00102	CbGpPWpGaD
Danazol—Thrombocytopenia—Dexamethasone—atopic dermatitis	4.2e-05	0.000725	CcSEcCtD
Danazol—Thrombocytopenia—Betamethasone—atopic dermatitis	4.2e-05	0.000725	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—CCR3—atopic dermatitis	4.2e-05	0.00101	CbGpPWpGaD
Danazol—Tachycardia—Dexamethasone—atopic dermatitis	4.19e-05	0.000723	CcSEcCtD
Danazol—Tachycardia—Betamethasone—atopic dermatitis	4.19e-05	0.000723	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—IL2—atopic dermatitis	4.17e-05	0.00101	CbGpPWpGaD
Danazol—Dyspepsia—Triamcinolone—atopic dermatitis	4.16e-05	0.000718	CcSEcCtD
Danazol—Dyspepsia—Methylprednisolone—atopic dermatitis	4.15e-05	0.000717	CcSEcCtD
Danazol—Hyperhidrosis—Dexamethasone—atopic dermatitis	4.15e-05	0.000716	CcSEcCtD
Danazol—Hyperhidrosis—Betamethasone—atopic dermatitis	4.15e-05	0.000716	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CCL17—atopic dermatitis	4.12e-05	0.000997	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—TAC1—atopic dermatitis	4.12e-05	0.000995	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—NPS—atopic dermatitis	4.12e-05	0.000995	CbGpPWpGaD
Danazol—Vertigo—Prednisone—atopic dermatitis	4.11e-05	0.00071	CcSEcCtD
Danazol—Syncope—Prednisone—atopic dermatitis	4.11e-05	0.000709	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—NPS—atopic dermatitis	4.09e-05	0.000988	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—TAC1—atopic dermatitis	4.09e-05	0.000988	CbGpPWpGaD
Danazol—Urticaria—Prednisolone—atopic dermatitis	4.08e-05	0.000705	CcSEcCtD
Danazol—Fatigue—Triamcinolone—atopic dermatitis	4.08e-05	0.000704	CcSEcCtD
Danazol—Fatigue—Methylprednisolone—atopic dermatitis	4.07e-05	0.000702	CcSEcCtD
Danazol—CCL2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	4.06e-05	0.0148	CbGdCrCtD
Danazol—GNRHR—GPCR downstream signaling—CXCR3—atopic dermatitis	4.04e-05	0.000976	CbGpPWpGaD
Danazol—Loss of consciousness—Prednisone—atopic dermatitis	4.02e-05	0.000694	CcSEcCtD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.02e-05	0.000971	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCR3—atopic dermatitis	4.01e-05	0.000969	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Fluocinonide—atopic dermatitis	4.01e-05	0.0146	CbGdCrCtD
Danazol—Urticaria—Hydrocortisone—atopic dermatitis	3.99e-05	0.000689	CcSEcCtD
Danazol—Body temperature increased—Hydrocortisone—atopic dermatitis	3.97e-05	0.000685	CcSEcCtD
Danazol—Convulsion—Prednisone—atopic dermatitis	3.97e-05	0.000685	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—IL1B—atopic dermatitis	3.96e-05	0.000957	CbGpPWpGaD
Danazol—Hypertension—Prednisone—atopic dermatitis	3.95e-05	0.000682	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Mometasone—atopic dermatitis	3.92e-05	0.0143	CbGdCrCtD
Danazol—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.91e-05	0.000675	CcSEcCtD
Danazol—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.91e-05	0.000675	CcSEcCtD
Danazol—CCL2—Fluorometholone—Desonide—atopic dermatitis	3.91e-05	0.0142	CbGdCrCtD
Danazol—Arthralgia—Prednisone—atopic dermatitis	3.9e-05	0.000673	CcSEcCtD
Danazol—CCL2—Amcinonide—Fluocinolone Acetonide—atopic dermatitis	3.89e-05	0.0142	CbGdCrCtD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.89e-05	0.00094	CbGpPWpGaD
Danazol—Anxiety—Prednisone—atopic dermatitis	3.88e-05	0.00067	CcSEcCtD
Danazol—CCL2—Flurandrenolide—Desonide—atopic dermatitis	3.88e-05	0.0141	CbGdCrCtD
Danazol—AR—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	3.87e-05	0.000936	CbGpPWpGaD
Danazol—Paraesthesia—Betamethasone—atopic dermatitis	3.85e-05	0.000665	CcSEcCtD
Danazol—Paraesthesia—Dexamethasone—atopic dermatitis	3.85e-05	0.000665	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—IL5—atopic dermatitis	3.83e-05	0.000925	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL5—atopic dermatitis	3.8e-05	0.000919	CbGpPWpGaD
Danazol—Dyspepsia—Dexamethasone—atopic dermatitis	3.78e-05	0.000652	CcSEcCtD
Danazol—Dyspepsia—Betamethasone—atopic dermatitis	3.78e-05	0.000652	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—CCL17—atopic dermatitis	3.77e-05	0.000912	CbGpPWpGaD
Danazol—Urticaria—Triamcinolone—atopic dermatitis	3.76e-05	0.000648	CcSEcCtD
Danazol—Urticaria—Methylprednisolone—atopic dermatitis	3.75e-05	0.000647	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.74e-05	0.000905	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—TAC1—atopic dermatitis	3.74e-05	0.000904	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—NPS—atopic dermatitis	3.74e-05	0.000904	CbGpPWpGaD
Danazol—Body temperature increased—Triamcinolone—atopic dermatitis	3.74e-05	0.000645	CcSEcCtD
Danazol—Oedema—Prednisone—atopic dermatitis	3.74e-05	0.000645	CcSEcCtD
Danazol—Fatigue—Dexamethasone—atopic dermatitis	3.7e-05	0.000638	CcSEcCtD
Danazol—Fatigue—Betamethasone—atopic dermatitis	3.7e-05	0.000638	CcSEcCtD
Danazol—Shock—Prednisone—atopic dermatitis	3.68e-05	0.000634	CcSEcCtD
Danazol—CCL2—Signaling Pathways—KIF3A—atopic dermatitis	3.68e-05	0.000888	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCR3—atopic dermatitis	3.67e-05	0.000886	CbGpPWpGaD
Danazol—Tachycardia—Prednisone—atopic dermatitis	3.65e-05	0.000629	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—MAPK8—atopic dermatitis	3.63e-05	0.000878	CbGpPWpGaD
Danazol—Hyperhidrosis—Prednisone—atopic dermatitis	3.61e-05	0.000623	CcSEcCtD
Danazol—Asthenia—Hydrocortisone—atopic dermatitis	3.6e-05	0.000622	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.56e-05	0.00086	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.56e-05	0.000859	CbGpPWpGaD
Danazol—Pruritus—Hydrocortisone—atopic dermatitis	3.55e-05	0.000613	CcSEcCtD
Danazol—CCL2—Beclomethasone—Mometasone—atopic dermatitis	3.51e-05	0.0128	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—IL5—atopic dermatitis	3.48e-05	0.00084	CbGpPWpGaD
Danazol—Urticaria—Betamethasone—atopic dermatitis	3.41e-05	0.000588	CcSEcCtD
Danazol—Urticaria—Dexamethasone—atopic dermatitis	3.41e-05	0.000588	CcSEcCtD
Danazol—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.4e-05	0.000588	CcSEcCtD
Danazol—Dizziness—Prednisolone—atopic dermatitis	3.4e-05	0.000587	CcSEcCtD
Danazol—Asthenia—Triamcinolone—atopic dermatitis	3.39e-05	0.000586	CcSEcCtD
Danazol—Body temperature increased—Betamethasone—atopic dermatitis	3.39e-05	0.000585	CcSEcCtD
Danazol—Body temperature increased—Dexamethasone—atopic dermatitis	3.39e-05	0.000585	CcSEcCtD
Danazol—Asthenia—Methylprednisolone—atopic dermatitis	3.39e-05	0.000584	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—KIF3A—atopic dermatitis	3.36e-05	0.000812	CbGpPWpGaD
Danazol—Paraesthesia—Prednisone—atopic dermatitis	3.36e-05	0.000579	CcSEcCtD
Danazol—Pruritus—Triamcinolone—atopic dermatitis	3.35e-05	0.000577	CcSEcCtD
Danazol—Pruritus—Methylprednisolone—atopic dermatitis	3.34e-05	0.000576	CcSEcCtD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	3.33e-05	0.000805	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCL11—atopic dermatitis	3.32e-05	0.000803	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CMA1—atopic dermatitis	3.32e-05	0.000803	CbGpPWpGaD
Danazol—Dizziness—Hydrocortisone—atopic dermatitis	3.32e-05	0.000573	CcSEcCtD
Danazol—CCL2—Clobetasol propionate—Desonide—atopic dermatitis	3.3e-05	0.012	CbGdCrCtD
Danazol—Dyspepsia—Prednisone—atopic dermatitis	3.29e-05	0.000568	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—CXCL10—atopic dermatitis	3.26e-05	0.000789	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Desonide—atopic dermatitis	3.26e-05	0.0119	CbGdCrCtD
Danazol—Rash—Prednisolone—atopic dermatitis	3.24e-05	0.00056	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CXCL10—atopic dermatitis	3.24e-05	0.000783	CbGpPWpGaD
Danazol—CCL2—Fluocinonide—Mometasone—atopic dermatitis	3.24e-05	0.0118	CbGdCrCtD
Danazol—Dermatitis—Prednisolone—atopic dermatitis	3.24e-05	0.000559	CcSEcCtD
Danazol—CCL2—Triamcinolone—Desonide—atopic dermatitis	3.23e-05	0.0118	CbGdCrCtD
Danazol—Fatigue—Prednisone—atopic dermatitis	3.22e-05	0.000556	CcSEcCtD
Danazol—Headache—Prednisolone—atopic dermatitis	3.22e-05	0.000556	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.21e-05	0.000775	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FCER2—atopic dermatitis	3.2e-05	0.000773	CbGpPWpGaD
Danazol—Constipation—Prednisone—atopic dermatitis	3.2e-05	0.000551	CcSEcCtD
Danazol—Vomiting—Hydrocortisone—atopic dermatitis	3.19e-05	0.000551	CcSEcCtD
Danazol—Rash—Hydrocortisone—atopic dermatitis	3.17e-05	0.000546	CcSEcCtD
Danazol—Dermatitis—Hydrocortisone—atopic dermatitis	3.16e-05	0.000546	CcSEcCtD
Danazol—Headache—Hydrocortisone—atopic dermatitis	3.15e-05	0.000543	CcSEcCtD
Danazol—CCL2—Fluorometholone—Fluocinonide—atopic dermatitis	3.13e-05	0.0114	CbGdCrCtD
Danazol—Dizziness—Triamcinolone—atopic dermatitis	3.13e-05	0.00054	CcSEcCtD
Danazol—CCL2—Signaling Pathways—STAT6—atopic dermatitis	3.13e-05	0.000755	CbGpPWpGaD
Danazol—Dizziness—Methylprednisolone—atopic dermatitis	3.12e-05	0.000538	CcSEcCtD
Danazol—CCL2—Flurandrenolide—Fluocinonide—atopic dermatitis	3.11e-05	0.0113	CbGdCrCtD
Danazol—CCL2—Amcinonide—Mometasone—atopic dermatitis	3.11e-05	0.0113	CbGdCrCtD
Danazol—Asthenia—Dexamethasone—atopic dermatitis	3.08e-05	0.000531	CcSEcCtD
Danazol—Asthenia—Betamethasone—atopic dermatitis	3.08e-05	0.000531	CcSEcCtD
Danazol—CCL2—Desoximetasone—Desonide—atopic dermatitis	3.07e-05	0.0112	CbGdCrCtD
Danazol—Nausea—Prednisolone—atopic dermatitis	3.05e-05	0.000527	CcSEcCtD
Danazol—CCL2—Fluorometholone—Fluocinolone Acetonide—atopic dermatitis	3.04e-05	0.0111	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—CMA1—atopic dermatitis	3.04e-05	0.000735	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL11—atopic dermatitis	3.04e-05	0.000735	CbGpPWpGaD
Danazol—Pruritus—Dexamethasone—atopic dermatitis	3.04e-05	0.000524	CcSEcCtD
Danazol—Pruritus—Betamethasone—atopic dermatitis	3.04e-05	0.000524	CcSEcCtD
Danazol—CCL2—Flurandrenolide—Fluocinolone Acetonide—atopic dermatitis	3.02e-05	0.011	CbGdCrCtD
Danazol—Vomiting—Triamcinolone—atopic dermatitis	3.01e-05	0.000519	CcSEcCtD
Danazol—Vomiting—Methylprednisolone—atopic dermatitis	3e-05	0.000518	CcSEcCtD
Danazol—Nausea—Hydrocortisone—atopic dermatitis	2.98e-05	0.000515	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	2.98e-05	0.000721	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	2.98e-05	0.000721	CbGpPWpGaD
Danazol—Rash—Triamcinolone—atopic dermatitis	2.98e-05	0.000515	CcSEcCtD
Danazol—Dermatitis—Triamcinolone—atopic dermatitis	2.98e-05	0.000514	CcSEcCtD
Danazol—CCL2—Diflorasone—Desonide—atopic dermatitis	2.98e-05	0.0108	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CCL22—atopic dermatitis	2.98e-05	0.000719	CbGpPWpGaD
Danazol—Rash—Methylprednisolone—atopic dermatitis	2.97e-05	0.000513	CcSEcCtD
Danazol—Dermatitis—Methylprednisolone—atopic dermatitis	2.97e-05	0.000513	CcSEcCtD
Danazol—Urticaria—Prednisone—atopic dermatitis	2.97e-05	0.000512	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—CXCL10—atopic dermatitis	2.96e-05	0.000716	CbGpPWpGaD
Danazol—Headache—Triamcinolone—atopic dermatitis	2.96e-05	0.000511	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—CXCL8—atopic dermatitis	2.96e-05	0.000716	CbGpPWpGaD
Danazol—Headache—Methylprednisolone—atopic dermatitis	2.96e-05	0.00051	CcSEcCtD
Danazol—Body temperature increased—Prednisone—atopic dermatitis	2.95e-05	0.00051	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	2.86e-05	0.000691	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT6—atopic dermatitis	2.86e-05	0.000691	CbGpPWpGaD
Danazol—Dizziness—Betamethasone—atopic dermatitis	2.84e-05	0.00049	CcSEcCtD
Danazol—Dizziness—Dexamethasone—atopic dermatitis	2.84e-05	0.00049	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—CCL5—atopic dermatitis	2.81e-05	0.000679	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—atopic dermatitis	2.81e-05	0.000679	CbGpPWpGaD
Danazol—Nausea—Triamcinolone—atopic dermatitis	2.81e-05	0.000485	CcSEcCtD
Danazol—Nausea—Methylprednisolone—atopic dermatitis	2.8e-05	0.000484	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CCL5—atopic dermatitis	2.79e-05	0.000674	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.74e-05	0.000662	CbGpPWpGaD
Danazol—Vomiting—Dexamethasone—atopic dermatitis	2.73e-05	0.000471	CcSEcCtD
Danazol—Vomiting—Betamethasone—atopic dermatitis	2.73e-05	0.000471	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CCR3—atopic dermatitis	2.71e-05	0.000655	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CXCL8—atopic dermatitis	2.71e-05	0.000654	CbGpPWpGaD
Danazol—Rash—Dexamethasone—atopic dermatitis	2.71e-05	0.000467	CcSEcCtD
Danazol—Rash—Betamethasone—atopic dermatitis	2.71e-05	0.000467	CcSEcCtD
Danazol—Dermatitis—Betamethasone—atopic dermatitis	2.7e-05	0.000466	CcSEcCtD
Danazol—Dermatitis—Dexamethasone—atopic dermatitis	2.7e-05	0.000466	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.7e-05	0.000652	CbGpPWpGaD
Danazol—Headache—Dexamethasone—atopic dermatitis	2.69e-05	0.000464	CcSEcCtD
Danazol—Headache—Betamethasone—atopic dermatitis	2.69e-05	0.000464	CcSEcCtD
Danazol—Asthenia—Prednisone—atopic dermatitis	2.68e-05	0.000463	CcSEcCtD
Danazol—PGR—Signaling Pathways—CCL27—atopic dermatitis	2.65e-05	0.000641	CbGpPWpGaD
Danazol—CCL2—Clobetasol propionate—Fluocinonide—atopic dermatitis	2.65e-05	0.00964	CbGdCrCtD
Danazol—Pruritus—Prednisone—atopic dermatitis	2.64e-05	0.000456	CcSEcCtD
Danazol—PGR—Generic Transcription Pathway—PPARA—atopic dermatitis	2.62e-05	0.000634	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Fluocinonide—atopic dermatitis	2.61e-05	0.00951	CbGdCrCtD
Danazol—CCL2—Budesonide—Desonide—atopic dermatitis	2.61e-05	0.0095	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Fluocinonide—atopic dermatitis	2.59e-05	0.00941	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Fluocinolone Acetonide—atopic dermatitis	2.57e-05	0.00936	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—CCL5—atopic dermatitis	2.55e-05	0.000617	CbGpPWpGaD
Danazol—Nausea—Dexamethasone—atopic dermatitis	2.55e-05	0.00044	CcSEcCtD
Danazol—Nausea—Betamethasone—atopic dermatitis	2.55e-05	0.00044	CcSEcCtD
Danazol—CCL2—Flunisolide—Fluocinolone Acetonide—atopic dermatitis	2.54e-05	0.00924	CbGdCrCtD
Danazol—GNRHR—GPCR downstream signaling—CCR5—atopic dermatitis	2.53e-05	0.000612	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	2.52e-05	0.00918	CbGdCrCtD
Danazol—CCL2—Signaling by GPCR—CCR5—atopic dermatitis	2.51e-05	0.000607	CbGpPWpGaD
Danazol—CCL2—Triamcinolone—Fluocinolone Acetonide—atopic dermatitis	2.51e-05	0.00915	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Hydrocortisone—atopic dermatitis	2.48e-05	0.00902	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—CCR3—atopic dermatitis	2.48e-05	0.000599	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.47e-05	0.000597	CbGpPWpGaD
Danazol—Dizziness—Prednisone—atopic dermatitis	2.47e-05	0.000426	CcSEcCtD
Danazol—CCL2—Desoximetasone—Fluocinonide—atopic dermatitis	2.46e-05	0.00894	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	2.45e-05	0.00892	CbGdCrCtD
Danazol—ESR1—AP-1 transcription factor network—IL6—atopic dermatitis	2.45e-05	0.000592	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Mometasone—atopic dermatitis	2.43e-05	0.00883	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—NPS—atopic dermatitis	2.42e-05	0.000584	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TAC1—atopic dermatitis	2.42e-05	0.000584	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Fluocinolone Acetonide—atopic dermatitis	2.39e-05	0.00869	CbGdCrCtD
Danazol—CCL2—Diflorasone—Fluocinonide—atopic dermatitis	2.38e-05	0.00868	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CCL17—atopic dermatitis	2.38e-05	0.000575	CbGpPWpGaD
Danazol—Vomiting—Prednisone—atopic dermatitis	2.38e-05	0.00041	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CXCR3—atopic dermatitis	2.37e-05	0.000572	CbGpPWpGaD
Danazol—Rash—Prednisone—atopic dermatitis	2.36e-05	0.000407	CcSEcCtD
Danazol—Dermatitis—Prednisone—atopic dermatitis	2.35e-05	0.000406	CcSEcCtD
Danazol—Headache—Prednisone—atopic dermatitis	2.34e-05	0.000404	CcSEcCtD
Danazol—CCL2—Diflorasone—Fluocinolone Acetonide—atopic dermatitis	2.32e-05	0.00843	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Dexamethasone—atopic dermatitis	2.3e-05	0.00838	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Betamethasone—atopic dermatitis	2.3e-05	0.00838	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—CCR5—atopic dermatitis	2.3e-05	0.000556	CbGpPWpGaD
Danazol—CCL2—Methylprednisolone—Triamcinolone—atopic dermatitis	2.25e-05	0.00819	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—IL5—atopic dermatitis	2.25e-05	0.000543	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—atopic dermatitis	2.25e-05	0.000543	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.23e-05	0.000539	CbGpPWpGaD
Danazol—Nausea—Prednisone—atopic dermatitis	2.22e-05	0.000383	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—NPS—atopic dermatitis	2.21e-05	0.000534	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TAC1—atopic dermatitis	2.21e-05	0.000534	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCR3—atopic dermatitis	2.17e-05	0.000524	CbGpPWpGaD
Danazol—CCL2—Methylprednisolone—Prednisone—atopic dermatitis	2.13e-05	0.00777	CbGdCrCtD
Danazol—PGR—Signaling Pathways—KIF3A—atopic dermatitis	2.12e-05	0.000512	CbGpPWpGaD
Danazol—CCL2—Budesonide—Fluocinonide—atopic dermatitis	2.09e-05	0.00761	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Prednisolone—atopic dermatitis	2.08e-05	0.00758	CbGdCrCtD
Danazol—CCL2—Metabolism of proteins—CXCL8—atopic dermatitis	2.08e-05	0.000503	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.08e-05	0.000502	CbGpPWpGaD
Danazol—CCL2—Beclomethasone—Betamethasone—atopic dermatitis	2.06e-05	0.00751	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Dexamethasone—atopic dermatitis	2.06e-05	0.00751	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—IL5—atopic dermatitis	2.05e-05	0.000496	CbGpPWpGaD
Danazol—CCL2—Clobetasol propionate—Mometasone—atopic dermatitis	2.05e-05	0.00747	CbGdCrCtD
Danazol—CCL2—Budesonide—Fluocinolone Acetonide—atopic dermatitis	2.03e-05	0.00739	CbGdCrCtD
Danazol—CCL2—Flunisolide—Mometasone—atopic dermatitis	2.03e-05	0.00737	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Triamcinolone—atopic dermatitis	2.02e-05	0.00734	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Mometasone—atopic dermatitis	2e-05	0.0073	CbGdCrCtD
Danazol—AR—Generic Transcription Pathway—PPARA—atopic dermatitis	2e-05	0.000483	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GLB1—atopic dermatitis	1.98e-05	0.000479	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Mometasone—atopic dermatitis	1.96e-05	0.00712	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Methylprednisolone—atopic dermatitis	1.94e-05	0.00704	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CMA1—atopic dermatitis	1.92e-05	0.000463	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL11—atopic dermatitis	1.92e-05	0.000463	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL10—atopic dermatitis	1.91e-05	0.000463	CbGpPWpGaD
Danazol—CCL2—Fluocinonide—Dexamethasone—atopic dermatitis	1.9e-05	0.00693	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Betamethasone—atopic dermatitis	1.9e-05	0.00693	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Mometasone—atopic dermatitis	1.9e-05	0.00693	CbGdCrCtD
Danazol—CYP19A1—Metabolism—ADSL—atopic dermatitis	1.9e-05	0.00046	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FCER2—atopic dermatitis	1.88e-05	0.000454	CbGpPWpGaD
Danazol—CCL2—Beclomethasone—Prednisolone—atopic dermatitis	1.87e-05	0.0068	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Triamcinolone—atopic dermatitis	1.86e-05	0.00677	CbGdCrCtD
Danazol—CCL2—Diflorasone—Mometasone—atopic dermatitis	1.85e-05	0.00673	CbGdCrCtD
Danazol—CCL2—Amcinonide—Betamethasone—atopic dermatitis	1.83e-05	0.00665	CbGdCrCtD
Danazol—CCL2—Amcinonide—Dexamethasone—atopic dermatitis	1.83e-05	0.00665	CbGdCrCtD
Danazol—PGR—Signaling Pathways—STAT6—atopic dermatitis	1.8e-05	0.000436	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Triamcinolone—atopic dermatitis	1.78e-05	0.0065	CbGdCrCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.77e-05	0.000427	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL10—atopic dermatitis	1.75e-05	0.000423	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL22—atopic dermatitis	1.75e-05	0.000422	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.72e-05	0.000415	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Prednisone—atopic dermatitis	1.69e-05	0.00616	CbGdCrCtD
Danazol—AR—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.68e-05	0.000405	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Prednisolone—atopic dermatitis	1.65e-05	0.00602	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—CCL5—atopic dermatitis	1.65e-05	0.000398	CbGpPWpGaD
Danazol—CCL2—Budesonide—Mometasone—atopic dermatitis	1.62e-05	0.0059	CbGdCrCtD
Danazol—CCL2—Betamethasone—Desonide—atopic dermatitis	1.6e-05	0.00581	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Desonide—atopic dermatitis	1.6e-05	0.00581	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CCR3—atopic dermatitis	1.56e-05	0.000378	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL27—atopic dermatitis	1.56e-05	0.000376	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARA—atopic dermatitis	1.54e-05	0.000372	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Hydrocortisone—atopic dermatitis	1.54e-05	0.00559	CbGdCrCtD
Danazol—GNRHR—GPCR downstream signaling—CXCL8—atopic dermatitis	1.53e-05	0.00037	CbGpPWpGaD
Danazol—CCL2—Flurandrenolide—Hydrocortisone—atopic dermatitis	1.53e-05	0.00556	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—NGF—atopic dermatitis	1.53e-05	0.000369	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL8—atopic dermatitis	1.52e-05	0.000367	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL5—atopic dermatitis	1.51e-05	0.000364	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCR5—atopic dermatitis	1.48e-05	0.000359	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—atopic dermatitis	1.46e-05	0.000353	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—atopic dermatitis	1.45e-05	0.000351	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Methylprednisolone—atopic dermatitis	1.45e-05	0.00528	CbGdCrCtD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.45e-05	0.000349	CbGpPWpGaD
Danazol—CCL2—Flurandrenolide—Methylprednisolone—atopic dermatitis	1.44e-05	0.00524	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Dexamethasone—atopic dermatitis	1.43e-05	0.00519	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Betamethasone—atopic dermatitis	1.43e-05	0.00519	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Betamethasone—atopic dermatitis	1.42e-05	0.00516	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Dexamethasone—atopic dermatitis	1.42e-05	0.00516	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—CCL17—atopic dermatitis	1.4e-05	0.000337	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NGF—atopic dermatitis	1.4e-05	0.000337	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Triamcinolone—atopic dermatitis	1.39e-05	0.00507	CbGdCrCtD
Danazol—PGR—Signaling Pathways—NPS—atopic dermatitis	1.39e-05	0.000337	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TAC1—atopic dermatitis	1.39e-05	0.000337	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL8—atopic dermatitis	1.39e-05	0.000336	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCR3—atopic dermatitis	1.37e-05	0.00033	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.36e-05	0.000329	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCR5—atopic dermatitis	1.36e-05	0.000328	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—atopic dermatitis	1.33e-05	0.000321	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Prednisone—atopic dermatitis	1.32e-05	0.00481	CbGdCrCtD
Danazol—ESR1—Signaling by ERBB4—IL6—atopic dermatitis	1.32e-05	0.000318	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL5—atopic dermatitis	1.29e-05	0.000313	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Prednisolone—atopic dermatitis	1.29e-05	0.0047	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Prednisolone—atopic dermatitis	1.28e-05	0.00467	CbGdCrCtD
Danazol—CCL2—Flunisolide—Hydrocortisone—atopic dermatitis	1.28e-05	0.00467	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Fluocinonide—atopic dermatitis	1.28e-05	0.00465	CbGdCrCtD
Danazol—CCL2—Betamethasone—Fluocinonide—atopic dermatitis	1.28e-05	0.00465	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Hydrocortisone—atopic dermatitis	1.27e-05	0.00462	CbGdCrCtD
Danazol—PGR—Gene Expression—PPARA—atopic dermatitis	1.26e-05	0.000305	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFKBIA—atopic dermatitis	1.26e-05	0.000304	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KIF3A—atopic dermatitis	1.24e-05	0.000301	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	1.24e-05	0.00452	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	1.24e-05	0.00452	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Methylprednisolone—atopic dermatitis	1.23e-05	0.00446	CbGdCrCtD
Danazol—CCL2—Flunisolide—Methylprednisolone—atopic dermatitis	1.21e-05	0.0044	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Betamethasone—atopic dermatitis	1.21e-05	0.00439	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Dexamethasone—atopic dermatitis	1.21e-05	0.00439	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Hydrocortisone—atopic dermatitis	1.21e-05	0.00439	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Methylprednisolone—atopic dermatitis	1.2e-05	0.00436	CbGdCrCtD
Danazol—CCL2—Flunisolide—Betamethasone—atopic dermatitis	1.19e-05	0.00433	CbGdCrCtD
Danazol—CCL2—Flunisolide—Dexamethasone—atopic dermatitis	1.19e-05	0.00433	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Triamcinolone—atopic dermatitis	1.18e-05	0.00429	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Betamethasone—atopic dermatitis	1.18e-05	0.00429	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Dexamethasone—atopic dermatitis	1.18e-05	0.00429	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	1.17e-05	0.00425	CbGdCrCtD
Danazol—CCL2—Flunisolide—Triamcinolone—atopic dermatitis	1.16e-05	0.00424	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	0.000278	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Betamethasone—atopic dermatitis	1.15e-05	0.00418	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	1.15e-05	0.00418	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Methylprednisolone—atopic dermatitis	1.14e-05	0.00414	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—CMA1—atopic dermatitis	1.13e-05	0.000272	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL11—atopic dermatitis	1.13e-05	0.000272	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	1.12e-05	0.00409	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Dexamethasone—atopic dermatitis	1.12e-05	0.00407	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Betamethasone—atopic dermatitis	1.12e-05	0.00407	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisone—atopic dermatitis	1.12e-05	0.00407	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CXCL10—atopic dermatitis	1.1e-05	0.000267	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Prednisone—atopic dermatitis	1.1e-05	0.00402	CbGdCrCtD
Danazol—CCL2—Diflorasone—Methylprednisolone—atopic dermatitis	1.1e-05	0.00402	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Triamcinolone—atopic dermatitis	1.09e-05	0.00398	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisone—atopic dermatitis	1.09e-05	0.00398	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisolone—atopic dermatitis	1.09e-05	0.00398	CbGdCrCtD
Danazol—CCL2—Diflorasone—Betamethasone—atopic dermatitis	1.09e-05	0.00395	CbGdCrCtD
Danazol—CCL2—Diflorasone—Dexamethasone—atopic dermatitis	1.09e-05	0.00395	CbGdCrCtD
Danazol—CCL2—Flunisolide—Prednisolone—atopic dermatitis	1.08e-05	0.00392	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisolone—atopic dermatitis	1.07e-05	0.00388	CbGdCrCtD
Danazol—CCL2—Diflorasone—Triamcinolone—atopic dermatitis	1.06e-05	0.00386	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—STAT6—atopic dermatitis	1.06e-05	0.000256	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Prednisone—atopic dermatitis	1.04e-05	0.00378	CbGdCrCtD
Danazol—CCL2—Budesonide—Hydrocortisone—atopic dermatitis	1.03e-05	0.00373	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Prednisolone—atopic dermatitis	1.01e-05	0.00369	CbGdCrCtD
Danazol—CCL2—Diflorasone—Prednisone—atopic dermatitis	1.01e-05	0.00367	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Mometasone—atopic dermatitis	9.91e-06	0.00361	CbGdCrCtD
Danazol—CCL2—Betamethasone—Mometasone—atopic dermatitis	9.91e-06	0.00361	CbGdCrCtD
Danazol—CCL2—Diflorasone—Prednisolone—atopic dermatitis	9.83e-06	0.00358	CbGdCrCtD
Danazol—CCL2—Budesonide—Methylprednisolone—atopic dermatitis	9.68e-06	0.00352	CbGdCrCtD
Danazol—AR—Gene Expression—PPARA—atopic dermatitis	9.62e-06	0.000232	CbGpPWpGaD
Danazol—CCL2—Budesonide—Betamethasone—atopic dermatitis	9.52e-06	0.00347	CbGdCrCtD
Danazol—CCL2—Budesonide—Dexamethasone—atopic dermatitis	9.52e-06	0.00347	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CCL5—atopic dermatitis	9.5e-06	0.00023	CbGpPWpGaD
Danazol—CCL2—Budesonide—Triamcinolone—atopic dermatitis	9.3e-06	0.00339	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—CCR3—atopic dermatitis	9.17e-06	0.000222	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—atopic dermatitis	8.98e-06	0.000217	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisone—atopic dermatitis	8.83e-06	0.00321	CbGdCrCtD
Danazol—PGR—Signaling Pathways—NGF—atopic dermatitis	8.8e-06	0.000213	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisolone—atopic dermatitis	8.62e-06	0.00314	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—IL2—atopic dermatitis	8.58e-06	0.000207	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCR5—atopic dermatitis	8.56e-06	0.000207	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—atopic dermatitis	8.54e-06	0.000206	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—atopic dermatitis	8.21e-06	0.000198	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TAC1—atopic dermatitis	8.18e-06	0.000198	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NPS—atopic dermatitis	8.18e-06	0.000198	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCR3—atopic dermatitis	8.02e-06	0.000194	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK8—atopic dermatitis	7.9e-06	0.000191	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—atopic dermatitis	7.85e-06	0.00019	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—atopic dermatitis	7.81e-06	0.000189	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL5—atopic dermatitis	7.6e-06	0.000184	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARA—atopic dermatitis	7.41e-06	0.000179	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKBIA—atopic dermatitis	7.26e-06	0.000175	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK8—atopic dermatitis	7.22e-06	0.000175	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL10—atopic dermatitis	6.48e-06	0.000157	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARA—atopic dermatitis	6.44e-06	0.000156	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Hydrocortisone—atopic dermatitis	6.27e-06	0.00228	CbGdCrCtD
Danazol—CCL2—Betamethasone—Hydrocortisone—atopic dermatitis	6.27e-06	0.00228	CbGdCrCtD
Danazol—CCL2—Betamethasone—Methylprednisolone—atopic dermatitis	5.92e-06	0.00215	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Methylprednisolone—atopic dermatitis	5.92e-06	0.00215	CbGdCrCtD
Danazol—CCL2—Betamethasone—Dexamethasone—atopic dermatitis	5.83e-06	0.00212	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Betamethasone—atopic dermatitis	5.83e-06	0.00212	CbGdCrCtD
Danazol—CYP3A4—Metabolism—GLB1—atopic dermatitis	5.79e-06	0.00014	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Triamcinolone—atopic dermatitis	5.69e-06	0.00207	CbGdCrCtD
Danazol—CCL2—Betamethasone—Triamcinolone—atopic dermatitis	5.69e-06	0.00207	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—CCL5—atopic dermatitis	5.58e-06	0.000135	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.55e-06	0.000134	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Prednisone—atopic dermatitis	5.4e-06	0.00197	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisone—atopic dermatitis	5.4e-06	0.00197	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisolone—atopic dermatitis	5.27e-06	0.00192	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisolone—atopic dermatitis	5.27e-06	0.00192	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CXCL8—atopic dermatitis	5.18e-06	0.000125	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGF—atopic dermatitis	5.17e-06	0.000125	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—atopic dermatitis	5.04e-06	0.000122	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR5—atopic dermatitis	5.03e-06	0.000121	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—atopic dermatitis	4.95e-06	0.00012	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—atopic dermatitis	4.61e-06	0.000111	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK8—atopic dermatitis	4.55e-06	0.00011	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKBIA—atopic dermatitis	4.26e-06	0.000103	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—atopic dermatitis	3.04e-06	7.34e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—atopic dermatitis	2.91e-06	7.03e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—atopic dermatitis	2.9e-06	7.02e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK8—atopic dermatitis	2.67e-06	6.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.88e-06	4.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—atopic dermatitis	1.71e-06	4.13e-05	CbGpPWpGaD
